Parallel Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.92K Hold
1,198
﹤0.01% 3239
2025
Q4
$1.64K Sell
1,198
-287
-19% -$379 ﹤0.01% 3188
2025
Q3
$1.84K Buy
+1,485
New +$1.77K ﹤0.01% 3070
2025
Q2
Sell
-114
Closed -$166 3542
2025
Q1
$166 Sell
114
-107
-48% -$202 ﹤0.01% 3406
2024
Q4
$471 Hold
221
﹤0.01% 3233
2024
Q3
$619 Hold
221
﹤0.01% 3144
2024
Q2
$515 Buy
+221
New +$652 ﹤0.01% 3091
2024
Q1
Sell
-32
Closed -$103 3297
2023
Q4
$103 Sell
32
-536
-94% -$1.52K ﹤0.01% 3229
2023
Q3
$1.8K Buy
568
+230
+68% +$1.01K ﹤0.01% 2858
2023
Q2
$1.68K Buy
338
+40
+13% +$216 ﹤0.01% 2800
2023
Q1
$1.47K Hold
298
﹤0.01% 2858
2022
Q4
$1.87K Buy
298
+174
+140% +$1.61K ﹤0.01% 2709
2022
Q3
$1K Sell
124
-464
-79% -$6.3K ﹤0.01% 2834
2022
Q2
$7K Sell
588
-286
-33% -$2.54K ﹤0.01% 2115
2022
Q1
$8K Sell
874
-402
-32% -$4.19K ﹤0.01% 2098
2021
Q4
$19K Hold
1,276
﹤0.01% 1803
2021
Q3
$33K Sell
1,276
-389
-23% -$9.23K ﹤0.01% 1485
2021
Q2
$43K Buy
1,665
+400
+32% +$11.4K ﹤0.01% 1316
2021
Q1
$45K Hold
1,265
﹤0.01% 1220
2020
Q4
$32K Sell
1,265
-134
-10% -$4.37K ﹤0.01% 1277
2020
Q3
$53K Buy
1,399
+477
+52% +$18K ﹤0.01% 1040
2020
Q2
$39K Sell
922
-130
-12% -$4.7K ﹤0.01% 1140
2020
Q1
$20K Buy
1,052
+800
+317% +$19.1K ﹤0.01% 1306
2019
Q4
$7K Hold
252
﹤0.01% 1840
2019
Q3
$7K Hold
252
﹤0.01% 1783
2019
Q2
$7K Hold
252
﹤0.01% 1695
2019
Q1
$7K Buy
+252
New +$7.31K ﹤0.01% 1654

Other funds holding ALLO